Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Degeneration Choroidal Neovascularization”

339 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 339 results

Large-scale testing (Phase 3)Ended earlyNCT00406744
What this trial is testing

Efficacy of Retreatments With Intravitreal Bevacizumab

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Asociación para Evitar la Ceguera en México 20
Testing effectiveness (Phase 2)Study completedNCT00510965
What this trial is testing

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Who this might be right for
Choroidal Neovascularization
University Hospital, Bonn 10
Not applicableActive Not RecruitingNCT04645212
What this trial is testing

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 23
Large-scale testing (Phase 3)Study completedNCT01922102
What this trial is testing

Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)
Novartis Pharmaceuticals 457
Testing effectiveness (Phase 2)UnknownNCT02857517
What this trial is testing

Intravitreal Conbercept for Idiopathic Choroidal Neovascularization

Who this might be right for
Idiopathic Choroidal Neovascularization
Jiao Mingfei 50
Early research (Phase 1)Study completedNCT01578720
What this trial is testing

Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome

Who this might be right for
Choroidal NeovascularizationPresumed Ocular Histoplasmosis
Retina Research Institute, LLC 5
Testing effectiveness (Phase 2)Study completedNCT00492284
What this trial is testing

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
QLT Inc. 162
Post-approval studies (Phase 4)UnknownNCT01246089
What this trial is testing

Ranibizumab for Myopic Neovascularization

Who this might be right for
Myopic Choroidal Neovascularization
Instituto de Olhos de Goiania 20
Not applicableStudy completedNCT04455399
What this trial is testing

Time Efficiency Comparison of Two IntraVitreal Injection Techniques

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion With Macular Edema+2 more
Peregrine Eye and Laser Institute 200
Not applicableStudy completedNCT00692887
What this trial is testing

Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 15
Early research (Phase 1)Study completedNCT00008515
What this trial is testing

Fluocinolone Implant to Treat Macular Degeneration

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
National Eye Institute (NEI) 16
Testing effectiveness (Phase 2)Study completedNCT00284089
What this trial is testing

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)
Novartis 88
Large-scale testing (Phase 3)Study completedNCT01716026
What this trial is testing

Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia

Who this might be right for
Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 66
Not applicableStudy completedNCT03897192
What this trial is testing

Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis

Who this might be right for
Punctate Inner Choroidopathy
Changhua Christian Hospital 14
Not applicableStudy completedNCT00748384
What this trial is testing

Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 30
Large-scale testing (Phase 3)Study completedNCT02307682
What this trial is testing

Efficacy and Safety of RTH258 Versus Aflibercept - Study 1

Who this might be right for
Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
Alcon Research 1,775
Not applicableStudy completedNCT00359008
What this trial is testing

PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 336
Not applicableStudy completedNCT02381730
What this trial is testing

Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment

Who this might be right for
Polypoidal Choroidal Vasculopathy
Fondation Ophtalmologique Adolphe de Rothschild 37
Early research (Phase 1)Study completedNCT03249740
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 32
Post-approval studies (Phase 4)Study completedNCT00473642
What this trial is testing

Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration

Who this might be right for
Age-Related MaculopathyChoroidal Neovascularization
Oklahoma State University Center for Health Sciences 31
Next Page